Malignant hyperthermia: what we may need to have at hand / Hipertermia maligna: lo que tendríamos que tener a la mano
Rev. colomb. anestesiol
;
49(4): e600, Oct.-Dec. 2021.
Article
in English
| LILACS, COLNAL
| ID: biblio-1341248
ABSTRACT
Malignant hyperthermia (MH) is often neglected in anesthesia because of its rare incidence (around 1100,000 general anesthetics). However, when it occurs, it becomes the anesthesiologist's nightmare. In the United States, Canada, and in most European countries, it is mandatory to store dantrolene wherever halogenated agents and/or succinylcholine are used by anesthesia providers (including sites that use only succinylcholine and no volatiles for electroconvulsive therapies). Unfortunately, its availability in Colombia is not mandatory or universal
RESUMEN
La hipertermia maligna (HM) es algo a menudo se descuida durante el acto anestésico debido a su muy baja incidencia (aproximadamente 1100.000 anestesias generales). Sin embargo, cuando se presenta, se convierte en una pesadilla para el anestesiólogo. En los Estados Unidos, Canadá y la mayoría de los países de Europa es obligatorio contar con dantroleno siempre que los anestesiólogos administran agentes halogenados y/o succinilcolina (incluidos los centros que utilizan succinilcolina sola sin agentes volátiles para terapias electroconvulsivas). En Colombia, infortunadamente, su disponibilidad no es obligatoria ni universal
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Malignant Hyperthermia
Limits:
Humans
Language:
English
Journal:
Rev. colomb. anestesiol
Journal subject:
Anesthesiology
Year:
2021
Type:
Article
Affiliation country:
Canada
/
Colombia
Institution/Affiliation country:
IPS Universitaria/CO
/
University of Toronto/CA
Similar
MEDLINE
...
LILACS
LIS